Tango Therapeutics, Inc. (TNGX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -44.36M | -29.72M | -30.95M | -36.52M | -41.7M | -36.65M | -33.39M | -23.61M | -37.86M | -27.47M | -31.14M | -24.47M |
| Operating CF Margin % | - | - | -57.52% | -1148.04% | -773.31% | -890.14% | -287.67% | -118.78% | -585.03% | -505.74% | -290.11% | -167.65% |
| Operating CF Growth % | -6.39% | 18.91% | 7.3% | -54.7% | -10.14% | -33.42% | -7.24% | 3.54% | -8.45% | 2.83% | -58.76% | 22.4% |
| Net Income | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M | -37.67M | -29.17M | -25.55M | -37.91M | -30.76M | -22.26M | -20.71M |
| Depreciation & Amortization | 463K | 479K | 555K | 625K | 622K | 620K | 622K | 632K | 625K | 617K | 613K | 604K |
| Stock-Based Compensation | 10.8M | 5.98M | 6.63M | 6.57M | 7.25M | 7.46M | 7.18M | 7.54M | 6.72M | 4.88M | 4.86M | 5.12M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -63K | 171K | 412K | 295K | 318K | 88K | -245K | -236K | -456K | -1.45M | 1.67M | 24K |
| Working Capital Changes | -10.04M | 2.4M | -54.43M | -5.16M | -10.02M | -7.15M | -11.78M | -5.99M | -6.83M | -750K | -16.02M | -9.51M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.78M | -1.23M | -344K | -880K | 1.63M | -2.51M | 3.05M | -2.77M | 1.04M | -88K | -1.96M | -1.21M |
| Cash from Investing | 9.63M | -135.72M | 47.48M | 16.78M | 30.6M | 52.06M | 32.57M | 12.7M | -11.2M | 33.85M | -56.66M | 32.69M |
| Capital Expenditures | -2K | -222K | -151K | -624K | -51K | -124K | -115K | -320K | -195K | -226K | -16K | -664K |
| CapEx % of Revenue | - | - | 0.28% | 19.62% | 0.95% | 3.01% | 0.99% | 1.61% | 3.01% | 4.16% | 0.15% | 4.55% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 79.85M | 219.38M | 2.54M | 581K | 2K | 969K | 2.4M | 1.31M | 42.98M | 1.47M | 80.28M | 586K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 80.38M | 219.41M | 2.54M | 581K | 0 | 0 | 0 | 0 | 41.72M | 0 | 79.84M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -537K | -36K | 0 | 0 | 2K | 969K | 2.4M | 1.31M | 1.26M | 1.47M | 441K | 586K |
| Net Change in Cash | 45.12M | 53.94M | 19.07M | -19.16M | -11.1M | 16.38M | 1.58M | -9.6M | -6.08M | 7.85M | -7.52M | 8.8M |
| Free Cash Flow | -44.36M | -29.94M | -31.1M | -37.14M | -41.75M | -36.77M | -33.51M | -23.93M | -38.05M | -27.69M | -31.15M | -25.14M |
| FCF Margin % | - | - | -57.8% | -1167.65% | -774.26% | -893.15% | -288.66% | -120.39% | -588.04% | -509.91% | -290.26% | -172.19% |
| FCF Growth % | -6.25% | 18.58% | 7.17% | -55.23% | -9.71% | -32.78% | -7.56% | 4.81% | -7.11% | 5.51% | -36.09% | 24.62% |
| FCF per Share | -0.31 | -0.26 | -0.28 | -0.34 | -0.38 | -0.34 | -0.31 | -0.22 | -0.35 | -0.29 | -0.32 | -0.28 |
| FCF Conversion (FCF/Net Income) | 0.97x | 0.77x | -1.95x | 0.94x | 1.05x | 0.97x | 1.14x | 0.92x | 1.00x | 0.89x | 1.40x | 1.18x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |